ICD-11 code 1F90.2 refers to a specific diagnosis within the international coding system known as intestinal helminthiasis, unspecified. Helminthiasis is a term used to describe the infestation of parasitic worms in the intestines, which can lead to various symptoms and complications.
This particular code is used when the specific type of intestinal worm infestation is not known or identified. While there are different types of worms that can infect the intestines, such as roundworms, hookworms, and tapeworms, the unspecified designation in this code indicates that the exact species is not specified.
Intestinal helminthiasis can cause symptoms such as abdominal pain, diarrhea, weight loss, fatigue, and malnutrition. Treatment for helminthiasis typically involves antiparasitic medications to kill and eliminate the worms from the intestines, as well as supportive care to manage any symptoms or complications that may arise.
Table of Contents:
- #️⃣ Coding Considerations
- 🔎 Symptoms
- 🩺 Diagnosis
- 💊 Treatment & Recovery
- 🌎 Prevalence & Risk
- 😷 Prevention
- 🦠 Similar Diseases
#️⃣ Coding Considerations
In the world of medical coding, the translation of codes from one classification system to another is crucial for accurate record-keeping and billing. The ICD-11 code 1F90.2, which refers to “Intestinal helminthiasis, unspecified,” can be equivalently represented in the SNOMED CT system as 203984000. This SNOMED CT code provides a more detailed and specific description of the condition, allowing for better communication and interoperability in healthcare settings. By using standardized code sets like SNOMED CT, healthcare professionals can more effectively document and track patients’ diagnoses, treatments, and outcomes. This harmonization of coding systems is essential for promoting quality care, accurate data analysis, and streamlined healthcare operations.
In the United States, ICD-11 is not yet in use. The U.S. is currently using ICD-10-CM (Clinical Modification), which has been adapted from the WHO’s ICD-10 to better suit the American healthcare system’s requirements for billing and clinical purposes. The Centers for Medicare and Medicaid Services (CMS) have not yet set a specific date for the transition to ICD-11.
The situation in Europe varies by country. Some European nations are considering the adoption of ICD-11 or are in various stages of planning and pilot studies. However, as with the U.S., full implementation may take several years due to similar requirements for system updates and training.
🔎 Symptoms
Symptoms of 1F90.2, also known as intestinal helminthiasis, are varied and can range from mild gastrointestinal issues to more severe complications. Common symptoms of this condition may include abdominal pain, diarrhea, bloating, gas, and weight loss. In some cases, individuals may experience nausea, vomiting, and fatigue as well.
Another common symptom of intestinal helminthiasis is the presence of worms in the stool or visible in the anal region. This can be a distressing and alarming symptom for individuals experiencing this condition. Additionally, some individuals may notice a decrease in appetite and a general feeling of weakness or malaise.
Severe cases of intestinal helminthiasis may lead to complications such as anemia, nutrient deficiencies, and intestinal blockages. These complications can further exacerbate symptoms and may require medical intervention to address. It is important for individuals experiencing persistent or worsening symptoms of intestinal helminthiasis to seek medical attention for proper diagnosis and treatment.
🩺 Diagnosis
Diagnosis of 1F90.2 (Intestinal helminthiasis, unspecified) typically involves a combination of medical history assessment, physical examination, laboratory tests, and imaging studies. Patients may present with symptoms such as abdominal pain, diarrhea, weight loss, and fatigue, which can raise suspicion for intestinal helminthiasis.
During the medical history assessment, the healthcare provider will inquire about the patient’s travel history, exposure to contaminated water or food, and any previous episodes of gastrointestinal symptoms. This information can help narrow down the potential causes of intestinal helminthiasis and guide further diagnostic testing.
A physical examination may reveal signs such as abdominal tenderness, bloating, and presence of a palpable mass in the abdomen. These findings, along with the patient’s symptoms, can further support the diagnosis of intestinal helminthiasis and prompt the healthcare provider to order additional tests to confirm the presence of helminth infections.
Laboratory tests, such as stool examinations, blood tests, and serologic assays, are commonly used to detect the presence of intestinal helminthiasis. Stool examinations are particularly useful for identifying helminth eggs or larvae in the feces, while blood tests can detect specific antibodies or antigens associated with certain helminth infections.
In some cases, imaging studies such as ultrasound, computed tomography (CT) scans, or magnetic resonance imaging (MRI) may be performed to assess the extent of infection and evaluate any complications of intestinal helminthiasis. These imaging studies can provide valuable information about the location of the helminths, the presence of any obstructive lesions, or the involvement of surrounding organs.
💊 Treatment & Recovery
Treatment for 1F90.2, Intestinal helminthiasis, unspecified, typically involves the use of anthelmintic medications to eliminate the parasitic worms from the intestines. These medications work by either killing the worms outright or causing them to detach from the intestinal walls, allowing them to be expelled from the body through bowel movements. The specific medication and treatment regimen prescribed may vary depending on the type of parasite causing the infection and the severity of the symptoms.
In addition to medication, supportive care may also be provided to manage any symptoms or complications associated with intestinal helminthiasis. This may include addressing issues such as dehydration, anemia, or malnutrition that can occur as a result of the infection. In severe cases, hospitalization may be necessary to provide more intensive treatment and monitoring.
Recovery from intestinal helminthiasis can vary depending on the individual’s overall health, the type of parasite involved, and how quickly treatment was initiated. In many cases, patients experience significant improvement in symptoms shortly after starting treatment with anthelmintic medications. However, follow-up testing may be needed to ensure that the infection has been completely eradicated and to monitor for any potential re-infection. It is important for patients to follow their healthcare provider’s instructions carefully and to complete the full course of treatment to prevent recurrence of the infection.
🌎 Prevalence & Risk
In the United States, the prevalence of 1F90.2 (Intestinal helminthiasis, unspecified) varies depending on geographical region. Despite efforts to control and prevent helminth infections, certain populations may still be at risk due to factors such as poor sanitation and lack of access to healthcare services. The incidence of intestinal helminthiasis may be higher in areas with lower socioeconomic status and limited resources for public health interventions.
In Europe, the prevalence of intestinal helminthiasis is generally low compared to other regions with higher burden of parasitic infections. However, sporadic cases of helminthiasis may still occur, particularly among immigrant populations from endemic countries or individuals with travel history to regions where helminthic infections are common. Awareness and surveillance of intestinal helminthiasis in Europe is essential to prevent potential outbreaks and ensure timely diagnosis and treatment of infected individuals.
In Asia, the prevalence of intestinal helminthiasis is significantly higher compared to Western countries due to factors such as poor sanitation, overcrowding, and lack of access to clean water sources. Helminthiasis remains a major public health concern in many Asian countries, particularly in rural areas where parasitic infections thrive in unsanitary conditions. Efforts to control and eliminate intestinal helminthiasis in Asia involve strategies such as mass drug administration, improved sanitation infrastructure, and health education initiatives targeted at at-risk populations.
In Africa, the prevalence of intestinal helminthiasis is highest, with certain regions experiencing widespread transmission of parasitic infections. Factors such as poverty, limited access to healthcare services, and inadequate sanitation contribute to the high burden of helminthiasis in Africa. Efforts to combat intestinal helminthiasis in Africa include mass deworming campaigns, water and sanitation projects, and health education programs to raise awareness about the risks of parasitic infections and promote preventive measures.
😷 Prevention
Preventing intestinal helminthiasis, specifically 1F90.2, involves a multifaceted approach beginning with maintaining good hygiene practices. One essential measure is ensuring access to clean and safe drinking water to prevent the transmission of helminth parasites. This can be achieved through proper sanitation and water treatment methods to eliminate potential sources of contamination.
In areas where intestinal helminthiasis is endemic, regular deworming programs can be implemented to reduce the prevalence of infection. Individuals at higher risk, such as children and individuals living in poverty, should be targeted for these interventions. Health education plays a crucial role in prevention efforts, as knowledge about the transmission routes and ways to avoid infection can empower individuals to protect themselves from helminthiasis.
Another important aspect of prevention is promoting good personal hygiene practices. This includes washing hands thoroughly with soap and water, especially before handling food, after using the toilet, and after contact with soil. The proper disposal of human waste and avoidance of open defecation are also essential to prevent the spread of intestinal helminthiasis. By adopting a comprehensive approach that addresses environmental, behavioral, and socio-economic factors, the burden of intestinal helminthiasis can be significantly reduced.
🦠 Similar Diseases
A closely related disease to 1F90.2 is Ascariasis (B77), which is caused by the roundworm Ascaris lumbricoides. This parasitic infection occurs predominantly in tropical and subtropical regions and is transmitted through ingestion of contaminated food or water. Symptoms can include abdominal pain, diarrhea, and malnutrition, with severe cases potentially leading to intestinal obstruction or complications in other organs.
Another comparable disease to 1F90.2 is Trichuriasis (B79), caused by the whipworm Trichuris trichiura. This parasitic infection primarily affects children in tropical and subtropical areas with poor sanitation. Symptoms may include abdominal pain, diarrhea, and rectal prolapse. Severe cases can result in anemia, growth retardation, and cognitive impairment.
Additionally, Enterobiasis (B80) shares similarities to 1F90.2 and is caused by the pinworm Enterobius vermicularis. This common intestinal parasitic infection is most prevalent in children and can spread easily within households and schools. Symptoms often include itching around the anus, especially at night, as well as restlessness and irritability. Treatment typically involves medications to eliminate the worms and reduce the risk of reinfection.